Clinical Application of Polyethylene Glycol Liposome Doxorubicin (PLD) in Primary Lymphoma

NCT02526823 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

360

Enrollment

OTHER_GOV

Sponsor class

Conditions

Lymphoma, Non-Hodgkin;Hodgkin Disease

Interventions

DRUG: R-CHOP/CHOPE or ABVD chemotherapy regimen
DRUG: R-CDOP/CDOPE or DBVD chemotherapy regimen

Sponsor

Shandong Provincial Hospital